Holgate, S. T.
Update on the SNG001 drug, an INFbeta therapy for COVID-19 [electronic resource] / Update on the SNG001 drug, an INFβ therapy for COVID-19 Update on the SNG001 drug, an Interferon-beta therapy for COVID-19 an interview with Stephen Holgate. - London : Henry Stewart Talks, 2020. - 1 online resource (1 streaming audio file (13 min.)). - Interviews on Covid-19, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19. .
Audio interview. Title from title frames.
Contents: An overview of SNG001 therapy -- Findings of the phase 2 clinical trial -- Treatment potential at different stages of the disease -- Advantages of the treatment delivery mode and accessibility -- Potential use as a prophylaxis treatment -- Follow up clinical trials to be undertaken -- Other treatment settings for INFβ.
Access restricted to subscribers.
Mode of access: World Wide Web.
8204 Henry Stewart Talks
Antiviral agents--Development.
Clinical trials.
Coronavirus infections--Chemotherapy.
COVID-19 (Disease)--Prevention.
COVID-19 (Disease)--Treatment.
Interferon.
Antiviral Agents--administration & dosage.
Clinical Trials, Phase II as Topic.
Coronavirus infections--drug therapy.
Coronavirus infections--prevention & control.
COVID-19--drug therapy.
COVID-19--prevention & control.
Interferon-beta--administration & dosage.
Interferon-beta--therapeutic use.
Nebulizers and Vaporizers.
Pneumonia, Viral--drug therapy.
Pneumonia, Viral--prevention & control.
Precision Medicine.
SARS-CoV-2.
Treatment Outcome.
Update on the SNG001 drug, an INFbeta therapy for COVID-19 [electronic resource] / Update on the SNG001 drug, an INFβ therapy for COVID-19 Update on the SNG001 drug, an Interferon-beta therapy for COVID-19 an interview with Stephen Holgate. - London : Henry Stewart Talks, 2020. - 1 online resource (1 streaming audio file (13 min.)). - Interviews on Covid-19, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19. .
Audio interview. Title from title frames.
Contents: An overview of SNG001 therapy -- Findings of the phase 2 clinical trial -- Treatment potential at different stages of the disease -- Advantages of the treatment delivery mode and accessibility -- Potential use as a prophylaxis treatment -- Follow up clinical trials to be undertaken -- Other treatment settings for INFβ.
Access restricted to subscribers.
Mode of access: World Wide Web.
8204 Henry Stewart Talks
Antiviral agents--Development.
Clinical trials.
Coronavirus infections--Chemotherapy.
COVID-19 (Disease)--Prevention.
COVID-19 (Disease)--Treatment.
Interferon.
Antiviral Agents--administration & dosage.
Clinical Trials, Phase II as Topic.
Coronavirus infections--drug therapy.
Coronavirus infections--prevention & control.
COVID-19--drug therapy.
COVID-19--prevention & control.
Interferon-beta--administration & dosage.
Interferon-beta--therapeutic use.
Nebulizers and Vaporizers.
Pneumonia, Viral--drug therapy.
Pneumonia, Viral--prevention & control.
Precision Medicine.
SARS-CoV-2.
Treatment Outcome.